A potential return to the helm of the US Food and Drug Administration by David Kessler would be a rare, but not unprecedented event in the history of the agency.
A Bloomberg report suggests that Kessler, who ran the agency from November 1990 through February 1997, and former principal deputy commissioner Joshua Sharfstein are
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?